Category: Breaking

Fauci Says U.S. Considering Allowing More Americans To Get First Dose Of Covid-19 Vaccine With Amended Approach

With the coronavirus killing more than 2,000 Americans per day in December, Dr. Fauci suggested that the U.S. Government might administer more first doses to increase immunizations nationwide.

U.K. Approves AstraZeneca-Oxford Covid-19 Vaccine For Emergency Use, With First Doses Being Rolled Out Next Week

The latest vaccine to be approved is cheaper and easier to store, and comes as Covid-19 infections and hospitalizations are spiking in Britain due largely to a new variant of the virus.

Biden Promises 100 Million Covid-19 Vaccinations In First 100 Days, Warning That Trump’s Approach Would Take ‘Years’

Biden warned that “things are going to get worse before they get better.”

Trump Administration Reaches Deal For 100 Million Additional Doses Of Pfizer’s Vaccine

The deal doubles the nation’s Pfizer vaccine doses.

U.K., India May Approve Cheaper Oxford-AstraZeneca Covid-19 Vaccine As Soon As Next Week

The AstraZeneca vaccine is easier and cheaper to manufacture, store and transport.

Report: Trump Administration Nears Deal For Additional Pfizer Vaccine Doses

The government had the opportunity to secure 600 million doses under an agreement signed in July.

South Carolina Gov. Henry McMaster Has Coronavirus

His office said he is experiencing mild symptoms.

Fauci, Azar Become First Public Figures To Receive Moderna’s Covid-19 Vaccine On Camera

The senior health officials are the latest to receive vaccines in public in order to boost public confidence, including President-elect Joe Biden and Vice President Mike Pence.

Pfizer-BioNTech, Moderna Test Vaccines Against New Covid-19 Variant Spreading Across U.K.

BioNTech’s CEO said on Tuesday that while it is currently unclear whether the vaccine can protect against the new U.K. strain, it is “highly likely” the shot can protect against new variants.

Feds Deploying More Than 400,000 Coronavirus Antibody Treatment Courses To States

The government started distributing Eli Lilly and Regeneron Pharmaceutical’s antibody treatments in November.